natgillin/translations-raw huggingface dataset:
ARICLAIM,,
Like all medicines, ARICLAIM can cause side effects, although not everybody gets them.
1 & 10
Very common side effects (these can affect more than 1 in 10 patients treated)with ARICLAIM when taken to treat stress urinary incontinence Feeling sick (nausea), dry mouth, and tiredness.
100 # '
Very common side effects (these can affect more than 1 in 10 patients treated)with ARICLAIM when taken to treat diabetic neuropathic pain Feeling sick (nausea), somnolence, headache, dizziness and constipation.
%
Common side effects (these can affect from 1 to 10 users in 100 patients treated) • Anxiety, having abnormal dreams. • Dizziness, tremor or numbness, including numbness or tingling of the skin. • Being sick (vomiting), heartburn or breaking wind, lack of appetite. • Blurred eyesight. • Feeling the heart pumping in the chest or hot flushes. • Problems getting an erection, changes in orgasm or less sex drive. • (itchy) Rash. • Muscle pain, muscle tightness or muscle spasm.
)
85 • Tasting things differently than usual, disturbance in attention or spasms and involuntary movements of the muscles. • Weight loss or weight gain, burping, indigestion or gastroenteritis. • Inflammation of the liver that may cause abdominal pain, tiredness or yellow coloration of the skin. • Vertigo, tinnitus (perception of sound in the ear when there is no external sound, ear pain. • Larger pupils (the dark centre of the eye) or visual disturbance. • Flushing, increase in blood pressure, feeling cold in your fingers and/ or toes, feeling dizzy (particularly when standing up too quickly), fast or irregular heart beat, night sweats, cold sweats, shivering or fainting. • Changes in ejaculation, abnormal periods, including heavy or prolonged periods • Allergic reactions, increased tendency to bruise, blisters or sensitivity to sunlight. • Muscle twitching. • Need to pass urine during the night or difficulty or inability to pass urine. • Grinding of teeth, dehydration, feeling hot/ cold, thirst, throat tightness or nose bleeds • Increased level of cholesterol in the blood.
• •
Rare side effects (these can affect from 1 to 10 users in 10,000 patients treated) • Mania (a disorder which symptoms are over activity, racing thoughts and decrease need for sleep), experiencing hallucinations • Increased level of sugar in the blood, low levels of sodium in the blood (the symptoms are feeling sick and unwell with weak muscles or confused), syndrome of inadequate secretion of anti-diuretic hormone (SIADH). • Bad breath. • Increased pressure in the eye. • Menopausal symptoms. • Sexual problems. • Abnormal manner of walking, contraction of the jaw muscle. • Decrease of activity of the thyroid gland, chest or stomach pain. • Need to pass more urine then usual or urine flow decreased.
,
Other possible side effects • Experiencing aggression and anger suicidal thoughts or behaviour. • A sensation of restlessness or an inability to sit or stand still, “ Serotonin syndrome” (a rare reaction which may cause feelings of great happiness, drowsiness, clumsiness, restlessness, feeling of being drunk, fever, sweating or rigid muscles), fits or stiffness. • Passing bright red blood in your stools vomiting blood, or black tarry stools (faeces). • Abnormal urine odour. • Yellow colouration of the skin (jaundice), hepatic failure, Stevens-Johnson syndrome, sudden swelling of skin of mucosa (angioedema).
,
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
1 & 10
86 5.
10 000 # '
HOW TO STORE ARICLAIM
ARICLAIM
Keep out of the reach and sight of children
+ +/ 0
Do not use ARICLAIM after the expiry date which is stated on the carton.
ARICLAIM
Store in the original pack.
30 °C.
Do not store above 30 °C.
+ / / $ARICLAIM &,
FURTHER INFORMATION
).
What ARICLAIM contains The active substance is duloxetine.
20
Each capsule contains 20 or 40 mg of duloxetine (as hydrochloride).
ARICLAIM
The other ingredients are:
ARICLAIM
Edible Ink:
ARICLAIM (
Black Iron Oxide-Synthetic (E172), Propylene glycol, Shellac.
40 mg
What ARICLAIM looks like and contents of the pack ARICLAIM is a hard gastro-resistant capsule.
2,
ARICLAIM is available in 2 strengths:
20
20 and 40 mg.
‘ 9544 ’.
The 20 mg capsule has an opaque blue body imprinted with ’ 20 mg’ and an opaque blue cap, imprinted with ‘ 9544’.
28, 56, 98, 140
ARICLAIM 40 mg is available in blister packs of 28, 56, 98, 140 and 196 (2 x 98) capsules.
ARICLAIM 20 mg.
ARICLAIM 20 mg is available in blister packs of 28 and 56 capsules.
,
Marketing Authorisation Holder:
:
Manufacturer:
Lilly S. A., Avda.
Lilly S. A., Avda.
De la Industria, 30, 28108 Alcobendas, Madrid,!
De la Industria, 30, 28108 Alcobendas, Madrid, Spain.
.
For any information about this medicine product, please contact the local representative of the Marketing Authorisation Holder.
Tél/ Tel: +32 27 73 33 11. / #, "+" '# "6.. - 6. + 359 2 491 41 40: eská republika Boehringer Ingelheim spol. s r. o.
Tél/ Tel: +32 27 73 33 11 България ТП "Ели Лили Недерланд "Б .В. - България тел. + 359 2 491 41 40 Č eská republika Boehringer Ingelheim spol. s r. o.
Tel.: + 42 02 34 65 51 11 Danmark Boehringer Ingelheim Danmark A/ S Tlf: +45 39 15 88 88 Deutschland Boehringer Ingelheim Pharma GmbH & Co.
Tel.: + 42 02 34 65 51 11
Tél/ Tel: +32 2 773 33 11 Magyarország Boehringer Ingelheim Pharma Tel.: +36 1 224 7120 Malta Boehringer Ingelheim Ltd.
Tél/ Tel: +32 2 773 33 11 Magyarország Boehringer Ingelheim Pharma Tel.: +36 1 224 7120 Malta Boehringer Ingelheim Ltd.
Tel: +356 25600 500 Nederland Boehringer Ingelheim b. v.
Tel: +356 25600 500
Tel: +31 30 6 02 59 14 Norge Boehringer Ingelheim Norway KS Tlf: +47 66 76 13 00 Österreich Boehringer Ingelheim Austria GmbH Tel: +43 1 710 3739
87 Danmark Boehringer Ingelheim Danmark A/ S Tlf: +45 39 15 88 88 Deutschland Boehringer Ingelheim Pharma GmbH & Co.
<? - @ A @@ B:. >.?. >.
KG Tel: +49 (0) 69 50 50 83 09 Eesti Boehringer Ingelheim Pharma GmbH Tel: + 37 2 60 80 940 Ελλάδα ΦΑΡΜΑΣΕΡΒ -ΛΙΛΛΥ Α .Ε .Β .Ε.
CD: +30 210 629 4600
Τηλ: +30 210 629 4600 España Dista S. A..
Tel: + 34 91 623 17 32 France Boehringer Ingelheim France S. A. S.
Tel: + 34 91 623 17 32 France Boehringer Ingelheim France S. A. S.
Tél: +33 3 26 50 45 33 Ireland Boehringer Ingelheim Ireland Ltd.
Tél: +33 3 26 50 45 33 Ireland Boehringer Ingelheim Ireland Ltd.
Tel: +353 - (0) 1 661 4377 Ísland Eli Lilly Danmark A/ S, Útibú á Íslandi Tel: + 354 520 34 00 Italia Eli Lilly Italia S. p. A.
Tel: +353-(0) 1 661 4377 Ísland Eli Lilly Danmark A/ S, Útibú á Íslandi Tel: + 354 520 34 00 Italia Eli Lilly Italia S. p. A.
Tel: + 39 - 055 42571 @ A C E
Tel: + 39- 055 42571 Κύπρος Boehringer Ingelheim Ellas A. E.
Tel: + 40 21 4023000 Slovenija Boehringer Ingelheim Pharma Tel.: +386 1 586 40 00 Slovenská republika Boehringer Ingelheim Pharma Tel.: +421 2 5341 8445 Suomi/ Finland Oy Eli Lilly Finland Ab Puh/ Tel: +358 9 8545 250
Tηλ: +30 2 10 89 06 300 Latvija Boehringer Ingelheim Pharma GmbH Tel: +37 167 24 00 68 Lietuva Boehringer Ingelheim Pharma Ges mbH Tel.: +370 37 47 39 22
BD Boehringer Ingelheim Ellas A. E.
Nederland Boehringer Ingelheim b. v.
Sverige Boehringer Ingelheim AB
Tel: +31 30 6 02 59 14 Norge Boehringer Ingelheim Norway KS Tlf: +47 66 76 13 00 Österreich Boehringer Ingelheim Austria GmbH Tel: +43 1 710 3739 Polska Boehringer Ingelheim Sp. z o. o.
E Latvija Boehringer Ingelheim Pharma GmbH Tel: +37 167 24 00 68 Lietuva Boehringer Ingelheim Pharma Ges mbH Tel.: +370 37 47 39 22
Tel.: +48 22 699 0 699 Portugal Boehringer Ingelheim, Lda Tel: +351 21 313 53 00 România Eli Lilly România S. R. L.
Tel: +46 8 721 21 00 United Kingdom Boehringer Ingelheim Ltd.
Tel: + 40 21 4023000 Slovenija Boehringer Ingelheim Pharma Tel.: +386 1 586 40 00 Slovenská republika Boehringer Ingelheim Pharma Tel.: +421 2 5341 8445 Suomi/ Finland Oy Eli Lilly Finland Ab Puh/ Tel: +358 9 8545 250 Sverige Boehringer Ingelheim AB Tel: +46 8 721 21 00 United Kingdom Boehringer Ingelheim Ltd.
Tel: +44 (0) 1256 315999
Tel: +44 (0) 1256 315999
+ # &
This leaflet was last approved in
('.',) http: // www. emea. europa. eu /
Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu.
ARICLAIM 30 mg + (1
88 PACKAGE LEAFLET:
ARICLAIM 60 mg + (1
INFORMATION FOR THE USER
) (Duloxetine (
ARICLAIM 30 mg hard gastro-resistant capsules ARICLAIM 60 mg hard gastro-resistant capsules Duloxetine (as hydrochloride)
. +.
- Keep this leaflet.
ARICLAIM ARICLAIM
- This medicine has been prescribed for you.
4.
Do not pass it on to others.
ARICLAIM
It may harm them, even
ARICLAIM 6.
if their symptoms are the same as yours.
*
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
%
please tell your doctor or pharmacist.
6 6
1.
ARICLAIM
How to take ARICLAIM 4.
$,
1.
$
ARICLAIM increases the levels of serotonin and norepinephrine in the nervous system.
,
There may be loss of feeling in the affected area, or sensations such as touch, heat, cold or pressure may cause pain.
.
Do not take ARICLAIM − If you are allergic (hypersensitive) to duloxetine or any of the other ingredients of ARICLAIM. − If you are taking or have recently taken within the last 14 days, another antidepressant medicine called a monoamine oxidase inhibitor (MAOI) (see also below in section: ‘ Taking other medicines’). − If you have liver disease. − If you have severe kidney disease. − If you are taking fluvoxamine which is usually used to treat depression, ciprofloxacin or enoxacine which are used to treat some infections. − If you suffer from uncontrolled high blood pressure.
ARICLAIM
If any of them apply to you, talk to your doctor before you take the medicine:
(* ARICLAIM -
- You are taking other medicines to treat depression.
,
John’ s Wort (Hypericum perforatum).
)
89
ARICLAIM. -
- You have kidney disease.
- MAO - $
- You have had seizures (fits).
(
- You suffer from or have suffered from mania or bipolar disorder.
.
- You have eye problems, such as certain kinds of glaucoma (increased pressure in the eye).
-
- You have a history of bleeding disorders (tendency to develop bruises).
+ ARICLAIM
- You are at risk of low sodium levels.
ARICLAIM
- You have high blood pressure.
$
- You are currently being treated with another medicine which may cause liver damage.
.
- You are taking other medicines containing duloxetine.
(Hypericum perforatum).
- You have intolerance to some sugars (see below).
ARICLAIM (
- You are considering stopping ARICLAIM (see section 3).
.
You should tell your doctor if this happens to you.
3).
These may be increased when first starting antidepressants, since these medicines all take time to work, usually about two weeks but sometimes longer.
18
Use in children and adolescents under 18 years of age ARICLAIM should normally not be used for children and adolescents under 18 years.
18
Despite this, your doctor may prescribe ARICLAIM for patients under 18 because he/ she decides that this is in their best interests.
18
If your doctor has prescribed ARICLAIM for a patient under 18 and you want to discuss this, please go back to your doctor.
18
You should inform your doctor if any of the symptoms listed above develop or worsen when patients under 18 are taking ARICLAIM.
,
The main ingredient of ARICLAIM, duloxetine, is used in other medicines for other conditions (depression and urinary incontinence).
ARICLAIM.)
Using more than one of these medicines at the same time should be avoided.
ARICLAIM
Monoamine Oxidase Inhibitors (MAOIs):
$ARICLAIM
You must wait at least 14 days
ARICLAIM $.
90 after you have stopped taking an MAOI before you can take ARICLAIM.
ARICLAIM,
Medicines that cause sleepiness:
ARICLAIM.
Tell your doctor if you are taking any medicines which cause you to be sleepy.
)
These medicines increase the risk of side effects; if you get any unusual symptom taking any of these medicines together with ARICLAIM, you should see your doctor.
ARICLAIM,
Oral -anticoagulants:
(ARICLAIM + 0 ARICLAIM
You should tell your doctor if you are taking oral – anticoagulants (medicines which thin the blood).
ARICLAIM.
These medicines might increase the risk of bleeding.
(
Care should be taken if you drink alcohol while you are being treated with ARICLAIM.
+
You should use ARICLAIM only after discussing the potential benefits and any potential risks to your unborn child with your doctor.
/ (
You should ask your doctor or pharmacist for advice if you are breast-feeding.
ARICLAIM. $ARICLAIM
Ask your doctor or pharmacist for advice before taking any medicine.
97 3.
3.
ARICLAIM%
HOW TO TAKE ARICLAIM
ARICLAIM 60 mg.
Always take ARICLAIM exactly as your doctor has told you.
,
The usual dose of ARICLAIM is 60 mg once a day, but your doctor will prescribe the dose that is right for you.
ARICLAIM.
ARICLAIM is for oral use.
ARICLAIM
You should swallow your capsule whole with a drink of water.
,
To help you remember to take ARICLAIM, you may find it easier to take it at the same times every day.
%
Talk with your doctor about how long you should keep taking ARICLAIM.
ARICLAIM.
Do not stop taking ARICLAIM without talking to your doctor.
ARICLAIM
If you take more ARICLAIM than you should
$
91 Call your doctor or pharmacist immediately if you take more than the amount of ARICLAIM prescribed by your doctor.
,
If you forget to take ARICLAIM Do not take a double dose to make up for a forgotten dose.
ARICLAIM
These symptoms are usually not serious and disappear within a few days, but if you have symptoms that are troublesome you should ask your doctor for advice.
1
If you have any further questions on the use of this product, ask your doctor or pharmacist.
%
These effects are normally mild to moderate and often disappear after a few weeks.
10
Very common side effects (these can affect more than 10 in 100 patients treated) Feeling sick (nausea), somnolence, headache or dizziness.
1 & 10
Very common side effects (these can affect more than 1 in 10 patients treated) Feeling sick (nausea), headache, dry mouth, and feeling sleepy.
1 000 # '%
Common side effects (these can affect from 1 to 10 users in 100 patients treated) • Tiredness, trouble sleeping, anxiety, feeling agitated or having abnormal dreams. • Dizziness, tremor or numbness, including numbness or tingling of the skin. • Diarrhoea, constipation, being sick (vomiting), heartburn, breaking wind, stomach pain. • Tinnitus (perception of sound in the ear when there is no external sound). • Blurred eyesight. • Feeling the heart pumping in the chest, flushing, increased sweating, night sweats • Problems getting an erection, less sex drive. • (Itchy) rash. • Muscle pain, muscle tightness, muscle spasm. • Increased yawning. • Lack of appetite, weight loss.
)
Uncommon side effects (these can affect from 1 to 10 users in 1,000 patients treated) • Throat inflammation. • Feeling disorientated, feeling sleepy, lack of motivation. • Tasting things differently than usual, disturbance in attention, stiffness, spasms and involuntary movements of the muscles, muscle twitching, abnormal manner of walking. • Poor sleep quality • Burping, indigestion, gastroenteritis • Vertigo, ear pain. • Inflammation of the liver that may cause abdominal pain 92 • Large pupils (the dark centre of the eye), visual disturbance. • Fast or irregular heart beat • Sexual problems, including changes in ejaculation, orgasm. • Abnormal periods, including heavy or prolonged periods. • Allergic reactions, increased tendency to bruise, blisters or sensitivity to sunlight • Increase in blood pressure, feeling cold in your fingers and/ or toes, feeling dizzy (particularly when standing up too quickly), cold sweats, shivering or fainting. • An increased level of sugar in the blood. • Need to pass more urine than normal, need to pass urine during the night, difficulty or inability to pass urine or having an urine flow decreased. • Grinding of teeth, feeling hot/ cold, thirst, throat tightness, nose bleeds. • Weight gain.
• -
Rare side effects (these can affect from 1 to 10 users in 10,000 patients treated) • Decrease of activity of the thyroid gland. • Dehydration. • Mania (a disorder which symptoms are over activity, racing thoughts and decrease need for sleep). • Bad breath. • Increased pressure in the eye. • Menopausal symptoms. • Contraction of the jaw muscle. • Increased level of cholesterol in the blood, low levels of sodium in the blood (the symptoms are feeling sick and unwell with weak muscles or confused), syndrome of inadequate secretion of anti-diuretic hormone (SIADH).
,
Other possible side effects • Hallucinations, suicidal thoughts, behaviour aggression and anger. • A sensation of restlessness or an inability to sit or stand still or “ Serotonin syndrome” (a rare reaction which may cause feelings of great happiness, drowsiness, clumsiness, restlessness, feeling of being drunk, fever, sweating or rigid muscles), fits. • Passing bright red blood in your stools, vomiting blood, or black tarry stools (faeces). • Having abnormal urine odour. • Chest pain. • Yellow colouration of the skin (jaundice), hepatic failure, Stevens-Johnson syndrome, sudden swelling of skin or mucosa (angioedema).
$#
5.
•) $. •.
Keep out of the reach and sight of children
(
Do not use ARICLAIM after the expiry date which is stated on the carton.
• # • •.
Store in the original package.
. „,
Do not store above 30°C.
• 3
93 6.
ARICLAIM
FURTHER INFORMATION
+ / / $ARICLAIM &,.
What ARICLAIM contains The active substance is duloxetine.
30
Each capsule contains 30 or 60 mg of duloxetine (as hydrochloride).
ARICLAIM
Edible White Ink: titanium dioxide (E171), propylene glycol, shellac, povidone.
.
What ARICLAIM looks like and contents of the pack ARICLAIM is a hard gastro-resistant capsule Each capsule of ARICLAIM contains pellets of duloxetine hydrochloride with a covering to protect them from stomach acid.
ARICLAIM
ARICLAIM is available in two strengths:
30
30 and 60 mg.
‘ 9543 ’.
ARICLAIM 30 mg is available in packs of 7, 28 and 98 capsules.
mg ’
ARICLAIM 60 mg is available in packs of 28 and 98 capsules.
‘ 9542 ’.
Not all pack sizes may be marketed.
ARICLAIM 30 mg ARICLAIM 60 mg
Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder:
De la Industria, 30, 28108 Alcobendas, Madrid,!
De la Industria, 30,28108 Alcobendas, Madrid, Spain.
.
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Tel.: + 42 02 34 65 51 11 Danmark Boehringer Ingelheim Danmark A/ S Tlf: +45 39 15 88 88 Deutschland Boehringer Ingelheim Pharma GmbH & Co.
Tel.: + 42 02 34 65 51 11 Danmark Boehringer Ingelheim Danmark A/ S Tlf: +45 39 15 88 88 Deutschland Boehringer Ingelheim Pharma GmbH & Co.
KG Tel: +49 (0) 69 50 50 83 09 Eesti Boehringer Ingelheim Pharma GmbH Tel: + 37 2 60 80 940; < =?
KG Tel: +49 (0) 69 50 50 83 09
Tel: +356 25600 500 Nederland Boehringer Ingelheim b. v.
Tel: +356 25600 500 Nederland Boehringer Ingelheim b. v.
Tel: +31 30 6 02 59 14 Norge Boehringer Ingelheim Norway KS Tlf: +47 66 76 13 00 Österreich Boehringer Ingelheim Austria GmbH Tel: +43 1 710 3739
Tel: +31 30 6 02 59 14 Norge Boehringer Ingelheim Norway KS Tlf: +47 66 76 13 00
<? - @ A @@ B:. >.?. >.
94 Eesti Österreich Boehringer Ingelheim Pharma GmbH Tel: + 37 2 60 80 940 Ελλάδα ΦΑΡΜΑΣΕΡΒ -ΛΙΛΛΥ Α .Ε .Β .Ε.
Tel.: +48 22 699 0 699 Portugal Boehringer Ingelheim, Lda Tel: +351 21 313 53 00 România Eli Lilly România S. R. L.
Tel.: +48 22 699 0 699 Portugal Boehringer Ingelheim, Lda Tel: +351 21 313 53 00 România Eli Lilly România S. R. L.
Tel: + 40 21 4023000 Slovenija Boehringer Ingelheim Pharma Tel.: +386 1 586 40 00 Slovenská republika Boehringer Ingelheim Pharma Tel.: +421 2 5341 8445 Suomi/ Finland Oy Eli Lilly Finland Ab Puh/ Tel: +358 9 8545 250
Tel: + 40 21 4023000 Slovenija Boehringer Ingelheim Pharma Tel.: +386 1 586 40 00 Slovenská republika Boehringer Ingelheim Pharma Tel.: +421 2 5341 8445 Suomi/ Finland Oy Eli Lilly Finland Ab Puh/ Tel: +358 9 8545 250 Sverige Boehringer Ingelheim AB Tel: +46 8 721 21 00 United Kingdom Boehringer Ingelheim Ltd.
$('.',) http: // www. emea. europa. eu /
Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu.
102
95
EMEA/ H/ C/ 403
EMEA/ H/ C/ 403
ARIXTRA
ARIXTRA
Arixtra съдържа активната вещество фондапаринукс натрий (1, 5, 2, 5, 5, 7, 5 или 10 mg в спринцовка).
Arixtra contains the active substance fondaparinux sodium (1.5, 2.5, 5, 7.5 or 10 mg per syringe).
Arixtra (концентрации 1, 5 и 2, 5 mg) се използва за предотвратяване на събития на венозна тромбоемболия (VTE, проблеми, причинени от кръвни съсиреци) при пациенти с тежки операции на краката, като поставяне на изкуствена тазобедрена става или операция при счупване на коляното или бедрената кост.
Arixtra (1.5 and 2.5 mg strengths) is used to prevent venous thromboembolic events (VTEs, problems caused by blood clots) in patients who are having major surgery to their legs, such as a hip replacement or surgery to repair a knee or hip fracture.
В по- високи концентрации (5, 7, 5 и 10 mg) Arixtra се използва при лечение на венозна тромбоемболия, като дълбока венозна тромбоза (DVT, кръвен съсирек в крака) или белодробен емболизъм (PE, кръвен съсирек в белия дроб).
At higher strengths (5, 7.5 and 10 mg), Arixtra is used to treat VTEs such as deep vein thrombosis (DVT, a blood clot in the leg) or pulmonary embolism (PE, blood clot in the lung).
Концентрацията от 2, 5 mg се използва и при лечение на пациенти с нестабилна стенокардия (вид гръдна болка с променлива сила), които имат инфаркт на миокарда (сърдечен удар): • без елевация на ST сегмента (ненормални показания в електрокардиограмата или ЕКГ) при пациенти, на които не предстои спешна ангиопластика (в рамките на два часа): ангиопластиката или „ перкутанна коронарна интервенция “ (PCI) е операция за отблокиране на кръвоносните съдове на сърцето; • с елевация на ST сегмента при пациенти, които приемат тромболитични лекарства (за лизиране на кръвния съсирек), или на които не предстои друго лечение за възстановяване на кръвотока към сърцето.
The 2.5 mg strength is also used to treat patients with unstable angina (a type of chest pain that changes in severity) or who are having a myocardial infarction (heart attack): • without ‘ ST segment elevation’ (an abnormal reading on the electrocardiogram or ECG) in patients who are not going to undergo urgent angioplasty (within two hours): angioplasty or ‘ percutaneous coronary intervention ’ (PCI) is an operation to unblock the heart ’ s blood vessels, • with ‘ ST segment elevation’ in patients who are receiving thrombolytic medicines (‘ clot busters’) or who are not about to receive any other treatment to restore blood flow to the heart.
За предотвратяване на VTE препоръчителната доза Arixtra е 2, 5 mg веднъж дневно, приложена чрез субкутанна инжекция (подкожно).
In the prevention of VTEs, the recommended dose of Arixtra is 2.5 mg once a day by subcutaneous injection (under the skin).
При пациенти
For patients who have kidney problems, Arixtra may not be suitable, or the 1.5-mg dose may be used.
7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
Treatment should be started as soon as possible after diagnosis and continued for up to eight days or until the patient is 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged с бъбречни проблеми Arixtra може да не е подходящ или да се приложи по- ниската доза от 1, 5 mg.
(44-20) 74 18 84 00 Fax (44-20) 74 18 86 68 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged discharged from hospital.
В зависимост от теглото на пациента дозата може да се регулира.
Arixtra is not recommended in patients who are about to undergo certain types of PCI.
Arixtra е антикоагулант, той предотвратява коагулирането (съсирването) на кръвта.
Arixtra is an anticoagulant: it prevents the blood from coagulating (clotting).